Notices
Essential Drugs Division
E-tender for the Procurement of ALGLUCOSIDASE ALFA FOR INTRAVENOUS INFUSION 50mg vial for SATH under NPRD for the year 2025-26 – Technical Bid Evaluation –Status– Published
Essential Drugs Division
Re-tender for the Procurement of Drugs/Supplies for the year 2025-26- Corrigendum- Published – r
Essential Drugs Division
Re-tender for the Procurement of Drugs/Supplies for the year 2025-26 -Time Extension Notice - Published
Essential Drugs Division
KMSCL –Re-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published – reg.
Essential Drugs Division
–Re-tender for the Procurement of Specialty Drugs for the year 2025-26- – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
KMSCL-Re-tender for the Procurement of Drugs/Supplies pre-bid meeting for the year 2025-26 - MEETING LINK
Essential Drugs Division
KMSCL - Re-tender for the Procurement of Drugs/Supplies for the year 2025-26- Amendment - Published
Essential Drugs Division
e-tender for the Procurement of Anticancer Drugs (Category ACD) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of SPECIALTY Drugs (Category SPL) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of Drugs (Category III - VIII) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of Drugs (Category III - VIII) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 - Price Bid Evaluation - Items Deferred - Final Bid Status - Published
Essential Drugs Division
Re-tender for the Procurement of Anti cancer Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/ACD/RT/2025/021 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/SPL/RT/2025/020 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Drugs/supplies for the year 2025-26 vide Re-tender No. KMSCL/ED/III to VIII/RT/2025/019 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26 vide Re-tender No. KMSCL/ED/I & II/RT/2025/018 dated 16.07.2025
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26 –Technical Bid Evaluation -List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation –List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
KMSCL- e-tender for the procurement of Drugs for Rare Disease for the year 2025-26
Essential Drugs Division
KMSCL- E-tender for the Procurement of Drugs/ Supplies ( category III- VIII) for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Anti- Cancer Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg
Essential Drugs Division
Technical Bid Evaluation of Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26
Essential Drugs Division
KMSCL- Re-tender for the procurement of Anti- Cancer Drugs for the year 2025-26
Essential Drugs Division
KMSCL- Re-tender for the procurement of Drugs/ Supplies (category-III-VIII) for the year 2025-26
Essential Drugs Division
"KMSCL- Re-tender for the Procurement of Bleaching Power for the year 2025-26".
Essential Drugs Division
KMSCL: Re-Tender for the procurement & supply of Drugs for Thalassemia for the year 2024-25 vide re-tender No-KMSCL/ED/THALASSEMIA DRUGS/RT/2025/013 dtd 28-06-2025.
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed/ status- Published- reg
Essential Drugs Division
KMSCL- Re- tender for the Procurement of Specialty Drugs for the year 2025-26- Technical Bid Evaluation- Defects noticed and status- Published
Essential Drugs Division
Notice for rejection/acceptance of item/bidder for price bid evaluation of e-tender for the procurement & supply of Salt Testing kit for NIDDCP for the year 2024-25
Essential Drugs Division
KMSCL Pre- tender zoom meeting vide e-tender for the procurement of Bleaching Powder 2025-26
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies for the year 2025-26 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published
Essential Drugs Division
E-tender for the Procurement of Drugs for the year 2025-26 -Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2025-26 -Price Bid Evaluation -Final Bid Status - Published
Essential Drugs Division
KMSCL e- tender for the procurement of Bleaching Powder for the year 2025-26
Essential Drugs Division
Procurement & Supply of Drugs for Ankylosing Spondylitis for KSSM for the year 2025-26
Essential Drugs Division
e-tender for the Procurement of drugs/supplies for the year 2025-26 - Technical Bid Evaluation - List of selected/Rejected/bidders/products for price bid evaluation published
Essential Drugs Division
Technical Bid Evaluation/Sample Evaluation of Tender for the procurement& supply of Salt testing Kit for NIDDCP for 2024-25
Essential Drugs Division
e-tender for the procurement of Drug for Palliative care for the year 2025-26
Essential Drugs Division
Re-tender for the Procurement and supply of drugs for Multiple Scieosis for KSSM for the year 2025-26
Essential Drugs Division
Procurement of Anti-Cancer Drugs for the year 2025-26 – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
Re-tender for the Procurement & Supply of Insecticides for NVBDCP & Plan Scheme for the year 2023-24 & 2024-25
Essential Drugs Division
Re-Tender for the Procurement of Test kits for NVBDCP AND PLAN FUND for the year 2023-24 AND 2024-25
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier-wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
e-tender for the procurement of drugs for the year 2025-26 - Price Bid Evaluation – Notice on Supplier-wise rate quoted and Provisional Bid Ranking Status– Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Drugs for the year 2025-26 ( category I&II) - Technical Bid Evaluation - List of selected/rejected bidders/products for Price Bid Evaluation- Published- reg
Essential Drugs Division
KMSCL-e- Tender for the procurement of Drugs for MULTIPLE SCLEROSIS FOR KSSM fro the year 2025-26
Essential Drugs Division
KMSCL- E- tender for the Procurement of Drugs/ Supplies for the year 2025-26- Technical Bid Evalution- Defects Noticed/ Status - Published- reg(Category III-VIII)
Essential Drugs Division
Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25– Price Bid Evaluation – FINAL Bid Status–published
Essential Drugs Division
E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25 –Price Bid Evaluation– Final Bid Status- Published
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed and status– Published
Essential Drugs Division
E-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed and status– Published
Essential Drugs Division
e-tender for the procurement of drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed/status – Published – reg"
Essential Drugs Division
Provisional Bid Status of E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25
Essential Drugs Division
E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25 vide etender No- KMSCL/ED/INS-NVBDCP&Plan/RC/2024/017
Essential Drugs Division
KMSCL – Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project for 2024-25– Price bid evaluation-Final Bid ranking status-–Published
Essential Drugs Division
KMSCL –E-Tender for Procurement & Supply of Drugs for Thalassemia Management for 2024-25 – Price bid evaluation-Final Bid ranking status – Published
Essential Drugs Division
KMSCL-E-tender for the Procurement of Deworming Medicines for the year 2024-25-Price Bid Evaluation- Final Bid status -Published
Essential Drugs Division
KMSCL-E-tender for the Procurement of Insecticides for NVBDCP & Plan fund for the year 2023-24 & 2024-25- List of selected/Rejected Bidders/ products for Price Bid Evaluation- published- reg
Essential Drugs Division
List of Selected/Rejected Bidders/ Products for Price Bid Evaluation-for– E-tender for the Procurement of Test kits for NVBDCP & Plan fund for 2023-24 & 2024-25 vide tender No- KMSCL/ED/NVBDCP &Plan Test Kits/RC/2024/022
Essential Drugs Division
KMSCL-E-Tender for the procurement & supply of Drugs for Thalassemia Management for 2024-25- Price bid evaluation- Provisional Bid ranking status- Published - reg
Essential Drugs Division
KMSCL-Re-Tender for the supply of Insulin Cartridge and pen for Mittayi Project for 2024-25- Price bid evaluation- Provisional Bid ranking status- Published - reg
Essential Drugs Division
KMSCL- E-tender for the Procurement of Deworming Medicines for the year 2024-25- Price Bid Evaluation- Notice on Supplier wise rate quoted and Provisional Bid Ranking Status- Published- reg
Essential Drugs Division
Re-Tender for the supply of Insulin Cartridge and Pen for Mittayi Project for 2024-25– List of selected/ rejected bidders/products for price bid evaluation-–Published–reg
Essential Drugs Division
E-Tender for Procurement & Supply of Drugs for Thalassemia Management for 2024-25 – List of Selected/Rejected Bidders/ Products for Price Bid Evaluation– Published – reg
Essential Drugs Division
KMSCL – E-tender for the Procurement of Deworming Medicines for the year 2024-25 – Technical Bid Evaluation –List of selected /rejected bidders/products for price bid evaluation– Published – reg
Essential Drugs Division
KMSCL- E- tender for the Procurement of Drug for Rare Disease for SATH under NPRD for the year 2024-25 - Bidder eligible for the Price Bid Evalution- Published- reg
Essential Drugs Division
E-tender for the Procurement of Veterinary Medicines for the year 2024-25 – Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
E-tender for the Procurement of IMIGLUCERASE for Injection 400 units for SATH under NPRD for the year 2024-25 – Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
KMSCL-E-tender for the Procurement of Deworming Medicines to the Animal Husbandry Department for the year 2024-25
Essential Drugs Division
KMSCL- E-tender for the Procurement of Veterinary Medicines for the year 2024-25- Technical Bid Evaluation - Defects noticed/status- Published- reg
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Drugs/Supplies (Category III-VIII) for the year 2024-25- Final Bid Status- Corrigendum- Published-reg.
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25 – Price Bid Evaluation – Final Bid status -Published – reg
Essential Drugs Division
KMSCL-E- tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2024-25- Price Bid Evaluation- Final Bid status- Published- reg. Vide e-tender No- KMSCL/ED/RD-SAT/RC/2024/019 dated. 27.09.2024
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Anti- cancer Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
KMSCL- Re-tender for the Procurement of Speciality Drugs for the year 2024-25- Price Bid Evaluation-Final Bid Status- Published- reg
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2024-25– Price Bid Evaluation – Final Bid Status– Published